Cargando…
High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.
High-dose chemotherapy with autologous bone marrow transplantation is used in the treatment of relapsed or high-risk Hodgkin's disease. As prospective randomised studies have proved difficult to accrue to, current recommendations are based on the reports of large series of prospectively collect...
Autores principales: | O'Brien, M. E., Milan, S., Cunningham, D., Jones, A. L., Nicolson, M., Selby, P., Hickish, T., Hill, M., Gore, M. E., Viner, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074518/ https://www.ncbi.nlm.nih.gov/pubmed/8630292 |
Ejemplares similares
-
Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.
por: Rubio, C., et al.
Publicado: (1997) -
High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
por: Zulian, G. B., et al.
Publicado: (1989) -
EPIC: an effective low toxicity regimen for relapsing lymphoma.
por: Hickish, T., et al.
Publicado: (1993) -
Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
por: Perren, T. J., et al.
Publicado: (1990) -
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
por: Selby, P., et al.
Publicado: (1990)